MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Aclaris Therapeutics ROA Ratio 2011-2026 | ACRS
Annual ROA Ratio Aclaris Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -59.94 | -44.82 | -34.14 | -36.17 | -72.07 | -164.15 | -48.17 | -28.14 | -27.3 | -21.86 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -21.86 | -164.15 | -53.68 |
Quarterly ROA Ratio Aclaris Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -28.26 | -24.09 | -22.75 | -20.71 | -34.11 | -43.35 | -49.08 | -38.21 | -45.66 | -39.72 | -35.46 | -24.04 | -32.07 | -24.34 | -30.65 | -32.15 | -47.2 | -54.24 | -64.32 | -53.46 | -109.74 | -150.96 | -185.31 | -145.23 | -159.22 | -114.83 | -75.42 | -48.17 | -43.6 | -39.19 | -33.95 | -28.14 | -25.24 | -23.84 | -25.06 | -27.3 | -25.8 | -31.03 | -26.47 | -21.86 | -31.79 | -35.78 | -33.02 | -30.24 | -15.29 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -15.29 | -185.31 | -49.56 |
ROA Ratio of other stocks in the Biotechnology industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-20.13 | - | 2.43 % | $ 254 M |  Germany |
 |
AgeX Therapeutics
AGE
|
-123.72 | - | -10.17 % | $ 12.2 K |  USA |
 |
Ascendis Pharma A/S
ASND
|
-35.36 | $ 213.28 | 1.91 % | $ 5 B |  Danmark |
 |
Alterity Therapeutics Limited
ATHE
|
-31.06 | $ 3.21 | - | $ 7.72 B |  Australia |
 |
Autolus Therapeutics plc
AUTL
|
-28.19 | $ 1.95 | -2.5 % | $ 498 M |  Britain |
 |
Albireo Pharma
ALBO
|
-11.27 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
-20.15 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
-49.57 | - | 4.14 % | $ 49.1 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.33 | - | - | $ 40.3 B | USA |
 |
Biophytis SA
BPTS
|
-89.6 | - | -13.47 % | $ 169 M |  France |
 |
Aeglea BioTherapeutics
AGLE
|
-34.19 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
-150.49 | - | -11.43 % | $ 502 K | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-53.39 | - | -1.52 % | $ 24.7 M | USA |
 |
Applied Molecular Transport
AMTI
|
-117.57 | - | - | $ 10.1 M | USA |
 |
Midatech Pharma plc
MTP
|
-42.28 | - | -18.52 % | $ 27.3 M | Britain |
 |
Aravive
ARAV
|
-122.8 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
-78.56 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
-144.48 | - | 3.77 % | $ 22.4 M | USA |
 |
Avenue Therapeutics
ATXI
|
-437.72 | - | -52.27 % | $ 4.45 M | USA |
 |
AIkido Pharma
AIKI
|
-31.2 | - | 1.93 % | $ 17.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
4.82 | - | - | - |  Russia |
 |
Can-Fite BioPharma Ltd.
CANF
|
-86.4 | $ 4.71 | 18.34 % | $ 10.2 B |  Israel |
 |
Catalyst Biosciences
CBIO
|
-73.35 | $ 10.94 | -1.17 % | $ 720 M | USA |
 |
ARCA biopharma
ABIO
|
-21.14 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-13.29 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
-40.29 | - | -15.15 % | $ 60.3 M | Britain |
 |
CollPlant Biotechnologies Ltd.
CLGN
|
-88.77 | $ 1.46 | 0.69 % | $ 16.7 M | Israel |
 |
Cellectis S.A.
CLLS
|
-32.74 | $ 4.55 | 3.06 % | $ 116 M | France |
 |
BioNTech SE
BNTX
|
65.02 | $ 100.08 | 2.03 % | $ 27.2 B | Germany |
 |
BioDelivery Sciences International
BDSI
|
26.14 | - | -4.8 % | $ 255 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
10.11 | $ 27.33 | -1.05 % | $ 1.32 B | USA |
 |
AVROBIO
AVRO
|
12.03 | - | 1083.1 % | $ 745 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
16.8 | $ 37.0 | 3.55 % | $ 3.82 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-10.89 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
CorMedix
CRMD
|
-56.47 | $ 11.17 | -0.8 % | $ 569 M | USA |
 |
CureVac N.V.
CVAC
|
-35.55 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
-225.71 | - | 2.71 % | $ 14 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-78.59 | $ 11.74 | 22.04 % | $ 759 M | USA |
 |
BioVie
BIVI
|
-81.36 | $ 1.35 | -2.88 % | $ 1.99 M | USA |
 |
Axon Enterprise
AXON
|
8.43 | $ 620.91 | -0.92 % | $ 47 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-489.29 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
-10.92 | $ 2.83 | 4.04 % | $ 17.8 M | USA |
 |
AstraZeneca PLC
AZN
|
0.11 | $ 95.16 | 0.21 % | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
-104.83 | - | -9.72 % | $ 5.89 M | USA |
 |
Acorda Therapeutics
ACOR
|
-232.99 | - | -24.86 % | $ 820 K | USA |
 |
Berkeley Lights
BLI
|
-43.36 | - | -7.31 % | $ 87 M | USA |
 |
Brickell Biotech
BBI
|
-49.15 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
5.51 | $ 9.29 | -0.05 % | $ 1.5 B | Britain |
 |
bluebird bio
BLUE
|
-34.23 | - | - | $ 546 M | USA |